Pictet Asset Management (UK)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
$302M Sell
871,921
-156,545
-15% -$54.2M 0.33% 86
2021
Q1
$288M Buy
1,028,466
+90,839
+10% +$25.4M 0.35% 78
2020
Q4
$230M Buy
937,627
+26,620
+3% +$6.52M 0.3% 102
2020
Q3
$258M Buy
911,007
+250,831
+38% +$71.2M 0.4% 68
2020
Q2
$177M Sell
660,176
-26,583
-4% -$7.11M 0.3% 99
2020
Q1
$217M Buy
686,759
+49,074
+8% +$15.5M 0.47% 57
2019
Q4
$189M Sell
637,685
-118,418
-16% -$35.1M 0.33% 90
2019
Q3
$176M Buy
756,103
+109,336
+17% +$25.5M 0.37% 76
2019
Q2
$151M Buy
646,767
+28,580
+5% +$6.68M 0.33% 97
2019
Q1
$146M Sell
618,187
-1,662
-0.3% -$393K 0.32% 91
2018
Q4
$187K Sell
619,849
-74,228
-11% -$22.3K 0.47% 47
2018
Q3
$245M Sell
694,077
-112,534
-14% -$39.8M 0.52% 39
2018
Q2
$234M Sell
806,611
-45,000
-5% -$13.1M 0.56% 33
2018
Q1
$233M Buy
851,611
+126,560
+17% +$34.7M 0.58% 29
2017
Q4
$231M Buy
725,051
+51,882
+8% +$16.5M 0.59% 28
2017
Q3
$211M Buy
673,169
+95,241
+16% +$29.8M 0.6% 28
2017
Q2
$143M Sell
577,928
-53,089
-8% -$13.2M 0.44% 62
2017
Q1
$173M Buy
631,017
+14,898
+2% +$4.07M 0.56% 36
2016
Q4
$175M Buy
616,119
+83,648
+16% +$23.7M 0.65% 31
2016
Q3
$167M Buy
532,471
+64,427
+14% +$20.2M 0.63% 33
2016
Q2
$136M Buy
468,044
+196,177
+72% +$56.8M 0.53% 44
2016
Q1
$70.5M Sell
271,867
-9,652
-3% -$2.5M 0.31% 92
2015
Q4
$86.2M Sell
281,519
-22,684
-7% -$6.95M 0.37% 74
2015
Q3
$88.8M Buy
304,203
+8,814
+3% +$2.57M 0.39% 64
2015
Q2
$94.2M Buy
295,389
+43,256
+17% +$13.8M 0.38% 70
2015
Q1
$94.3M Buy
252,133
+32,101
+15% +$12M 0.39% 60
2014
Q4
$74.7M Buy
220,032
+46,220
+27% +$15.7M 0.33% 75
2014
Q3
$57.5M Sell
173,812
-22,383
-11% -$7.4M 0.28% 92
2014
Q2
$61.9M Buy
196,195
+16,200
+9% +$5.11M 0.29% 93
2014
Q1
$55.1M Sell
179,995
-2,600
-1% -$795K 0.28% 96
2013
Q4
$51.1M Buy
182,595
+1,300
+0.7% +$364K 0.26% 106
2013
Q3
$43.6M Sell
181,295
-9,500
-5% -$2.29M 0.24% 112
2013
Q2
$41.1M Buy
+190,795
New +$41.1M 0.23% 107